Pfizer

The new deal effectively doubles the federal government's order from the company. Pfizer says the U.S. government has agreed to pay $1.95 billion for the additional doses.

Operation Warp Speed, the government effort to fast-track coronavirus vaccines, has lived up to its name: A new vaccine for a new disease is here in…

Pfizer is pushing back on the Trump administration's suggestion that the company is having trouble producing enough COVID-19 vaccine.

Scientists and investors born outside the U.S. played crucial roles in the development of COVID-19 vaccines — a remarkable vindication for the argument that innovation depends on immigration.

Updated: 5:15 p.m., Wednesday, Dec. 16, 2020 Cleveland-area hospital employees began receiving the Pfizer-BioNTech COVID-19 Vaccine Wednesday. Dr. Sherrie Williams, a pulmonary critical care specialist, was the first MetroHealth employee to receive the COVID-19 shot. "I'd be lying if I said I wasn't nervous," Dr. Williams said, minutes before she received the shot. Despite her initial fears, Williams later said the vaccine felt like any other shots she has ever received and she felt fine after.

Updated: 2:40 p.m., Tuesday, Dec. 15, 2020 The first Pfizer-BioNTech COVID-19 Vaccine doses have arrived in Northeast Ohio. Cleveland Clinic, MetroHealth, the Louis Stokes VA Medical Center in Cleveland, as well as Aultman Hospital in Canton, all received shipments Tuesday morning. Cleveland Clinic and Aultman received their vaccines shortly after 9 a.m., while MetroHealth got its allocation around 8:45 a.m. – a little earlier than hospital officials had expected.

The Food and Drug Administration finds "no specific safety concerns" that would stand in the way of authorization of the vaccine for emergency use. Effectiveness is 95% after two doses.

The U.K. was the first Western country to approve Pfizer's coronavirus vaccine for emergency use. In the U.S., the Food and Drug Administration could vote to approve the vaccine as early as Thursday.

A British regulatory agency approved the Pfizer/BioNTech vaccine Wednesday. It could be dispersed within days to the neediest people, government officials said.

The vaccine was found to be 95% effective in an updated study analysis. Safety data required by the Food and Drug Administration showed no serious concerns, the company said.